Callan Family Office LLC Purchases New Holdings in Cigna Group $CI

Callan Family Office LLC purchased a new stake in Cigna Group (NYSE:CI) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 33,797 shares of the health services provider’s stock, valued at approximately $9,317,000.

Several other institutional investors also recently modified their holdings of the company. Norges Bank bought a new position in Cigna Group in the fourth quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. increased its holdings in Cigna Group by 13,333.2% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after buying an additional 3,141,844 shares during the period. Dodge & Cox increased its holdings in Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after buying an additional 1,833,389 shares during the period. Boston Partners raised its stake in shares of Cigna Group by 314.6% in the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after buying an additional 1,243,056 shares in the last quarter. Finally, GQG Partners LLC raised its stake in shares of Cigna Group by 14.3% in the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock valued at $2,136,699,000 after buying an additional 972,302 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 0.6%

CI opened at $276.19 on Friday. The firm has a market cap of $72.98 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.94 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The firm’s 50-day simple moving average is $284.20 and its 200-day simple moving average is $281.38. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s payout ratio is 25.82%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CI. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. The Goldman Sachs Group increased their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Guggenheim raised their price target on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Robert W. Baird set a $362.00 price objective on Cigna Group in a report on Friday, July 31st. Finally, Cantor Fitzgerald upped their price objective on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 23,012 shares of company stock worth $6,386,550 over the last three months. 0.60% of the stock is owned by company insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.